Insider Selling: Cardlytics (NASDAQ:CDLX) CEO Sells $56,394.00 in Stock

Key Points

• Amit Gupta, Cardlytics' CEO, sold 54,225 shares on April 2 at $1.04 for $56,394 and has sold roughly 219,789 shares in recent months (about $214k total), trimming his stake by 4.88% to 1,057,220 shares.
• Shares jumped 13% to $1.13 on Thursday on heavy volume (2.14M vs. average 1.04M), giving the company a market cap of about $62.2 million.
• Cardlytics reported an EPS miss (‑$0.15 vs. est. ‑$0.07) and negative profitability metrics, and analysts carry a consensus "Reduce" rating with an average price target of $1.75.

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CEO Amit Gupta sold 54,225 shares of Cardlytics stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $1.04, for a total transaction of $56,394.00. Following the completion of the sale, the chief executive officer owned 1,057,220 shares of the company's stock, valued at $1,099,508.80. This trade represents a 4.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Amit Gupta also recently made the following trade(s):

• On Wednesday, April 1st, Amit Gupta sold 62,549 shares of Cardlytics stock. The shares were sold at an average price of $0.99, for a total value of $61,923.51.
• On Wednesday, February 18th, Amit Gupta sold 45,159 shares of Cardlytics stock. The stock was sold at an average price of $0.93, for a total value of $41,997.87.
• On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The shares were sold at an average price of $0.90, for a total value of $46,844.10.
• On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The shares were sold at an average price of $1.17, for a total value of $6,794.19.

Cardlytics Stock Up 13.0%

NASDAQ:CDLX traded up $0.13 on Thursday, reaching $1.13. 2,137,597 shares of the company's stock were exchanged, compared to its average volume of 1,043,434. The firm has a market capitalization of $62.23 million, a price-to-earnings ratio of -0.58 and a beta of 0.91. Cardlytics, Inc. has a 52-week low of $0.66 and a 52-week high of $3.28. The business has a fifty day moving average of $0.90 and a 200-day moving average of $1.34.

Cardlytics (NASDAQ:CDLX - Get Free Report) last released its earnings results on Wednesday, March 4th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.08). Cardlytics had a negative return on equity of 370.98% and a negative net margin of 44.36%.The business had revenue of $56.10 million for the quarter, compared to analyst estimates of $54.46 million. As a group, equities analysts anticipate that Cardlytics, Inc. will post -1.52 earnings per share for the current year.

Wall Street Analyst Weigh In

CDLX has been the subject of several analyst reports. Bank of America reissued an "underperform" rating on shares of Cardlytics in a research note on Thursday, March 5th. Evercore set a $1.00 price objective on Cardlytics in a research note on Friday, March 6th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Cardlytics in a research report on Monday, December 29th. Two research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Reduce" and an average price target of $1.75.

Institutional Investors Weigh In On Cardlytics

Several institutional investors have recently modified their holdings of CDLX. XTX Topco Ltd grew its stake in shares of Cardlytics by 143.5% during the second quarter. XTX Topco Ltd now owns 85,971 shares of the company's stock worth $141,000 after purchasing an additional 50,663 shares in the last quarter. Marshall Wace LLP acquired a new stake in Cardlytics in the second quarter valued at $59,000. Sand Hill Global Advisors LLC purchased a new stake in Cardlytics during the 2nd quarter worth about $35,000. Jane Street Group LLC lifted its holdings in Cardlytics by 263.0% during the 2nd quarter. Jane Street Group LLC now owns 162,427 shares of the company's stock worth $267,000 after buying an additional 117,687 shares during the last quarter. Finally, Global Retirement Partners LLC boosted its position in shares of Cardlytics by 67.3% during the 3rd quarter. Global Retirement Partners LLC now owns 34,800 shares of the company's stock worth $85,000 after acquiring an additional 14,000 shares in the last quarter. 68.10% of the stock is owned by hedge funds and other institutional investors.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers' online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics' offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.